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Balancing the generation of immune responses capable of controlling virus replication
with those causing immunopathology is critical for the survival of the host and reso-
lution of influenza-induced inflammation. Based on the capacity of interleukin-6 (IL-6)
to govern both optimal T-cell responses and inflammatory resolution, we hypothesised
that IL-6 plays an important role in maintaining this balance. Comparison of innate and
adaptive immune responses in influenza-infected wild-type control and IL-6-deficient
mice revealed striking differences in virus clearance, lung immunopathology and gener-
ation of heterosubtypic immunity. Mice lacking IL–6 displayed a profound defect in their
ability to mount an anti-viral T-cell response. Failure to adequately control virus was fur-
ther associated with an enhanced infiltration of inflammatory monocytes into the lung
and an elevated production of the pro-inflammatory cytokines, IFN-α and TNF-α. These
events were associated with severe lung damage, characterised by profound vascular
leakage and death. Our data highlight an essential role for IL-6 in orchestrating anti-viral
immunity through an ability to limit inflammation, promote protective adaptive immune
responses and prevent fatal immunopathology.
Keywords: Adaptive immunity · Heterosubtypic immunity · IL-6 · Innate immunity · Pulmonary
damage
 Additional supporting information may be found in the online version of this article at thepublisher’s web-site
Introduction
Seasonal influenza infects 5–15% of the global population annu-
ally and results in significant morbidity and mortality [1]. Fatal
infections are characterised by severe respiratory failure, which
is associated with a profound early inflammatory infiltrate, lung
haemorrhage and cytokine release [2–4]. Disease severity may
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therefore reflect the balance between immune-mediated control
of virus replication and the extent of virus-driven immunopathol-
ogy. The co-ordinate activities of the innate and adaptive immune
systems are likely to contribute to this balance. In order to exam-
ine this relationship, we studied the role that the cytokine, IL-6,
plays in maintaining this balance. We considered this important,
as IL-6 has been reported to correspond with the magnitude of
strain-independent viral replication and disease severity both in
animal models and in humans [5, 6]. Recent data using a mouse
model of influenza infection indicate that mice lacking IL-6 are
less likely to survive the infection thereby implying a beneficial
effect of IL-6 in controlling the infection [7].
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The impact of IL-6 on the host response to influenza infection
could be wide ranging. IL-6 regulates inflammation and orches-
trates the transition from innate to adaptive immune responses
([8–10] and reviewed in [11]). In this context, IL-6 has a signifi-
cant influence on the development of adaptive immunity. Indeed,
mice lacking IL-6 are more susceptible to infection with a range of
pathogens including Mycobacterium tuberculosis, Listeria monocy-
togenes, vaccinia virus and vesicular stomatitis virus, where in each
case compromised pathogen clearance was linked to generation
of suboptimal T-cell responses in the knockout animals [12–14].
Furthermore, IL-6 deficient (IL-6−/−) mice demonstrate resistance
to antigen-induced arthritis and autoimmune encephalomyelitis
[15, 16]. A role for IL-6 in promoting both CD8+ and CD4+
T-cell activities has been described and range from a requirement
for the cytokine for optimal T-cell priming, differentiation, com-
mitment, migration and effector function ([12–14, 17, 18] and
reviewed in [19]). Using the human influenza virus E61–13-H17
(H17), which causes only a subclinical infection in mice, we previ-
ously reported diminished influenza-specific CD4+ T-cell memory
responses in IL-6−/− mice [20]. Overall, these data imply that the
role of IL-6 in influenza infection is protective. We hypothesised
that IL-6 would promote viral clearance, while offering protection
against virus-induced lung pathology. Specifically, IL-6 control of
innate immune responses would limit infection-associated tissue
damage, whilst promoting optimal adaptive immunity resulting in
viral clearance. To address these points, we examined the ability
of wild type (WT) and IL-6−/− mice to control primary infection
with the mouse adapted influenza virus, A-PR8–34 (PR8) and
subsequently secondary infection with A/X31 (X31). Unlike the
human virus used in our previous study, PR8 replicates efficiently
in mice and can cause fatal disease [21]. We compared viral clear-
ance, development of innate and adaptive immune responses, and
infection-associated lung pathology. We conclude that IL-6 plays
a pivotal role in supporting an anti-viral host defence and helps to
limit excessive tissue injury.
Results
IL-6−/− mice succumb to sublethal doses of PR8
Both WT mice and mice lacking IL-6 demonstrate severe weight
loss upon infection with 50 pfu of the pathogenic, mouse-adapted
influenza strain, PR8 (Fig. 1A) in agreement with a previous pub-
lication [7]. From day 8 post-infection, WT mice began to regain
weight and all mice survived the infection. In contrast, a significant
proportion of IL–6−/− mice failed to recover (Fig. 1B). As a further
indicator of morbidity in the infected animals, body temperature
was measured at the same time points. Following infection, all
mice became hypothermic around 5 days post-infection and whilst
Figure 1. IL-6−/− mice experience enhanced mortality and morbidity with delayed viral clearance during acute influenza infection. (A, B) WT
and IL-6−/− mice were infected i.n. with 50 pfu of PR8 and monitored daily for weight loss. The (A) percentage of initial weight and (B) Kaplan–
Meier survival curves are shown and significance determined using the log-rank test (**p < 0.01). (C) Core body temperature was determined on
a daily basis as an indication of morbidity. (D) Lungs were harvested from the mice at the time-points indicated and the pulmonary viral load
quantified. **p< 0.01, Mann–Whitney test. Results are expressed as themean + SEM, n= 6mice/group from one experiment representative of three
performed.
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Figure 2. Acute influenza infection induces an enhanced proinflammatory cytokine response in IL-6−/− mice. BALF was aspirated at day 2, 4 or 7
post-infection from WT and IL-6−/− mice infected with 50 pfu of PR8. (A) TNF-α, (B) IFN-α, (C) IL-1β and (D) IFN-γ levels present in the BALF were
determined by ELISA. Results are expressed as the mean + SEM, n = 6 mice/group from one experiment representative of two performed. The
significances of differences between WT and IL-6−/− mice was assessed using Mann–Whitney test, *p < 0.05, **p < 0.01.
therewas no significant difference between the two groups, a trend
towards greater reduction in core body temperature was observed
in IL-6−/− mice (Fig. 1C). Whilst a hypothermic state is not typical
during human influenza infection, reduced core body temperature
during influenza infection is associated with increased morbidity
and mortality in mice [22]. To determine whether the increased
disease severity observed in the IL-6−/− mice relates to a fail-
ure to control virus replication, lungs from infected animals were
recovered and virus titres assessed at three time points (days 2,
4 and 7) post-infection. Peak viral titres were observed at day 4
in infected WT animals after which the infection was controlled.
However, IL–6−/− mice displayed a compromised ability to control
influenza infection, as viral titres continued to increase up to day
7, post-infection (Fig. 1D).
Influenza infected IL-6−/− mice exhibit increased
inflammatory cytokines and monocytic cells
To confirm the presence of IL-6 during influenza infection, IL-6
levels in WT mice were measured. We found that IL-6 was sig-
nificantly elevated following influenza virus infection (Supporting
Information Fig. 1A). In this regard, a robust acute phase response
was elicited in WT mice, evidenced by an IL-6-dependent increase
in systemic levels of serum amyloid-A in these animals (Support-
ing Information Fig. 1B). It was therefore predicted that impaired
anti-viral immunity might also be associated with a reduced innate
response to infection. Surprisingly, pro-inflammatory mediators
associated with the activation of innate immune response were
increased and BALF from infected IL–6−/− mice (day 7 post-
infection) contained significantly elevated levels of TNF-α and
IFN-α, and had a trend for greater IFN-γ and IL-1β as compared
with that in WT controls (Fig. 2).
To further compare the extent of the inflammatory response in
infected IL-6−/− and WT mice, BALF was recovered and the total
number of leukocytes analysed by flow cytometry. NK cells, neu-
trophils and inflammatory monocytes were assessed in the BALF
of WT and IL-6−/− mice at days 2, 4 and 7 post-infection (Fig. 3A–
D and Supporting Information Fig. 2). We observed no significant
differences in the numbers of NK cells and neutrophils at any of
the time points tested (Fig. 3B and C). However, there was a sig-
nificant increase in the numbers of inflammatory monocytes in
pulmonary exudates from IL-6−/− mice as compared with that in
WT controls (Fig. 3D).
Phenotypic analysis of these cells revealed striking differences
between WT and IL-6−/− mice, with a substantial increase in the
proportion of inflammatory monocytes producing TNF-α within
the lungs of infected IL-6−/− mice (Fig. 4A) and an accompanying
increase in BALF CCL2 levels (Fig. 4B).
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Figure 3. IL-6−/− mice exhibit exacerbated influenza induced airway inflammation. BALF was aspirated fromWT and IL-6−/− mice at days 2, 4 and
7 and the airway infiltrating cells were isolated. (A) The total numbers of cells and the numbers of (B) NK cells, (C) neutrophils and (D) inflammatory
monocytic cells, at the selected time points were determined by flow cytometry. The mean score + SEM for each group is given, n = 6 mice/group,
from one experiment representative of three performed. The significances of differences between WT and IL-6−/− mice were determined using
Mann–Whitney test, ***p ≤ 0.001
Influenza infection of IL-6−/− mice is characterised by
vascular leakage and severe lung damage
Such exaggeration of the pro-inflammatory environment in the
lungs of infected IL–6−/− mice might be expected to correlate with
greater pulmonary pathology. When lung sections from influenza
challenged mice were compared, both WT and IL-6−/− displayed
severe occlusion of the alveolar airspaces (Fig. 5A, B, H and Sup-
porting Information Table 1). However tissue damage was more
pronounced in IL–6−/− mice. Indeed, comparison of lungs at day
9 post-infection revealed an enormous disparity between IL-6−/−
mice (that had survived the initial infection) and WT mice (that
controlled the viral infection). Extensive haemorrhage into the
airway spaces (Fig. 5G), leukocyte infiltration and perivascular
aggregation was observed in the lungs of IL–6−/− mice. In con-
trast, pulmonary pathology had almost completely resolved in WT
animals (Fig. 5D, E and H).
The greater degree of haemorrhage observed in the lungs of
the IL-6−/− mice implies enhanced vascular leakage in infected
IL-6−/− lungs compared with those of WT mice. This was con-
firmed by comparison of serum albumin levels in the lungs of
both groups of infected mice (Fig. 5I). Overall, these data point
towards a failure of the IL-6−/− mice to control both viral load
and to limit the excessive recruitment of damaging inflammatory
monocytic cells to the lung. This inability to appropriately control
the inflammatory response ultimately causes fatal damage.
IL-6 is required for optimal activation of
influenza-specific T-cell responses
We next examined T-cell responses in WT and IL-6−/− mice
infected with 50 pfu of the influenza strain, PR8. We observed
a trend for fewer CD4+ T cells and IFN-γ-producing CD4+
T cells in the BALF of IL-6−/− compared with WT mice (Fig. 6A).
The total number of CD8+ NP34-tetramer-positive and IFN-γ-
producing CD8+ T cells were, however, markedly reduced in BALF
recovered from IL-6−/− mice (Fig. 6B and C). As IL-6 is known to
facilitate migration of T cells to inflamed sites, it was possible that
the paucity of T cells in the lungs of IL-6−/− mice reflected impaired
T-cell migration [23]. Further analysis of tetramer-positive CD8+
T cells in themediastinal lymph node however, also revealed lower
numbers of these cells in mice lacking IL-6 compared with WT
mice (Fig. 6D). This implies a defect at the level of T-cell prim-
ing and/or expansion in the IL-6−/− mice. When we examined the
phenotype of dendritic cells purified from the lung draining lymph
nodes, we found no difference either in number or expression
levels of MHC class II, CD80 or CD86 between both groups of
mice (Supporting Information Fig. 5).
As IL-6 also controls T-cell proliferation and T-cell apoptosis,
we assessed influenza-specific T cells in both IL-6−/− and WTmice
according to these parameters [24]. Specifically, we measured
expression of the protein Ki-67, observed in proliferating cells, and
the anti-apoptotic gene Bcl2, which protects cells from apoptosis
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Figure 4. Pulmonary inflammatory monocytic cells exhibit an altered
phenotype in IL-6−/− mice. (A) BALF was aspirated fromWT and IL-6−/−
mice at day 7 and the airway infiltrating cells isolated. BAL cells were
stimulated for 5 h in vitrowith LPS, thenumbers of inflammatorymono-
cytic cells secreting TNF-α were determined by flow cytometry. (B) The
presence of the chemokine CCL2 was determined in BALF at day 7 by
ELISA. Results are expressed as themean ± SEM, n= 6mice/group from
one experiment representative of two performed. The significances of
differences between WT and IL-6−/− mice were assessed using Mann–
Whitney test, *p < 0.05, ***p < 0.001.
(Fig. 7A and B). Whilst the total number and proportion of CD8+
T cells proliferating were comparable between both groups of mice
(Fig. 7C) the total number of proliferating influenza-specific CD8+
T cells were significantly reduced in the IL-6−/− mice (Fig. 7D).
The total number and proportion of Ki67+ pulmonary infiltrating
CD4+ T cells were also significantly diminished in the absence of
IL-6 (Fig. 7E). Further analysis of the CD8+ , Tetramer+ CD8+ and
CD4+ T cells indicated a trend towards reduced proportions of
cells expressing Bcl2 in IL-6−/− compared to WT mice (Fig. 7 F, G
and H).
IL-6 is required for establishing effective
heterosubtypic immunity
As the memory response to influenza virus is thought to reflect
the magnitude of the primary response in WT animals [25], we
surmised that the generation of T-cell immunity against a differ-
ent influenza A virus subtype (heterosubtypic immunity) would
be impaired in the IL-6−/− animals. To address this, we infected
groups of WT and IL-6−/− animals with 25 pfu PR8 virus. This
lower dose was chosen for this part of the study to guarantee
recovery and survival of all experimental mice after primary infec-
tion (Supporting Information Fig. 3). Mice were rechallenged with
X31, a heterosubtypic strain of influenza virus, which shares a
number of T-cell receptor epitopes to those displayed by PR8
virus, but not neutralising antibody determinants. The applica-
tion of these heterosubtypic influenza strains therefore allows us
to specifically examine expansion of influenza-specific memory
T cells and their ability to confer protective immunity. Pulmonary
viral load at day 4 post-secondary infection demonstrated a signif-
icant decrease in viral titres in WT memory mice compared with
those inWT na¨ıvemice, however, the same effect was not observed
in the IL-6−/− mice demonstrating a deficiency in their ability to
control a second infection (Fig. 8B). This finding was reflected
in the weight loss measurements as IL-6−/− but not WT mice,
lost a comparable amount of weight upon X31 challenge as mice
that had not previously been exposed to the PR8 virus (Fig. 8A).
Influenza-specific tetramer staining indicated a notable reduction
in the number of antigen-experienced CD8+ T cells recalled to the
lungs during the second infection in IL-6−/− mice (Fig. 8C). The
impaired ability to control X31 in PR8-primed IL-6−/− animals was
also associated with lower numbers of CD4+ T cells in the BALF
following challenge (Fig. 8D). As a further measure of the antigen-
specific memory CD4+ T-cell response, the influenza-specific
proliferative capacity of CD4+ T cells, purified from mice 7–
9 weeks following the resolution of the primary infection was
significantly reduced in IL-6−/− mice (Fig. 8E). Overall, these
data reflect early events during the primary phase of influenza
infection confirming that the influenza–specific T-cell memory
response is significantly compromised in the IL-6−/− animals.
A further striking feature of IL-6−/− animals rechallenged with
X31 was the extent of pulmonary damage observed during
the second infection (Fig. 8F). In particular, significant haem-
orrhage was observed in the lungs of IL-6−/− mice (Fig. 8F
and H), substantiating earlier observations that pulmonary dam-
age during the primary infection results in lung leakiness that
appears to be exacerbated by IL-6 deficiency during a subsequent
infection.
Discussion
In this study, we found that IL-6 has a significant impact on the
severity of influenza virus infection rendering animals less able to
control virus and more susceptible to lethal disease. Both innate
and adaptive immune responses to influenza virus were affected
by the absence of IL-6 reflecting the pleiotropic nature of the
cytokine and also its role in co-ordinating the activities of these
different arms of the immune system.
Both WT and IL-6-deficient mice showed a similar disease
course in that all mice from both groups lost weight following
influenza virus infection and, as reported previously, the mice
experienced a hypothermic response rather than fever during the
acute phase of infection [26]. Despite a previous report indicat-
ing that during the first 5 days post-influenza infection, WT mice
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Figure 5. IL-6−/− mice exhibit increased pulmonary immunopathology during acute influenza infection. Lungs were harvested from mice at the
days indicated post-infection and following perfusion were formalin fixed, embedded in paraffin wax, sectioned and stained with haematoxylin
and eosin. Representative sections from influenza infected, (A and D) WT and (B and E) IL-6−/− mice were compared with those from (C and F)
uninfected WT mice at day 7 (top) and day 9 (bottom). Arrowheads highlight areas of lymphocytic perivascular aggregate, asterisks highlight
areas of leukocyte infiltration into the airway spaces, and H indicates areas of haemorrhage (original magnification ×20, scale bar 100 μm).
(G) A representative section illustrating the extent of haemorrhage observed in IL-6−/− mice at day 9 post-infection is shown (original magnification
× 20). (H) The mean total histopathology score ± SEM for WT and IL-6−/− mice is given, n = 6 mice/group from one experiment representative of
three performed. (I) The level of serum albumin, a protein indicative of damage to the pulmonary epithelium, was determined in BALF at day 7
by ELISA. Results are expressed as the mean ± SEM, n = 6 mice/group from one experiment representative of two performed. The significances of
differences between WT and IL-6−/− mice were assessed using Mann–Whitney test. *p < 0.05.
experience a greater dip in body temperature compared to mice
lacking IL-6, we observed no significant differences. The disparity
in the findings of the two studies may reflect the doses of virus
used to infect the mice: approximately three times more virus was
used in our study, ensuring a greater extent of infection in both
the WT and IL-6−/− animals. In our study, the biggest difference
between WT and IL-6−/− mice occurred at day 8 post-infection;
WT mice started to regain weight from day 9 whilst IL-6−/− mice
did not. Similar findings were reported in a recent study by Dienz
et al. [27] who demonstrated that whilst WT mice recovered from
influenza virus infection, mice lacking IL-6 did not.
The severity of disease in the IL-6−/− mice is associated with
a failure to control influenza virus. The effect of this failure is
profound, perpetuating virus-driven inflammatory responses and
results in life-threatening immunopathology. This is characterised
by an elevation in local pro-inflammatory cytokine production,
most notably IFN-α, and an associated increase in CCL2 and
enhanced inflammatory monocytic cell recruitment to the lung.
Several independent reports have confirmed a critical role for
CCL2-mediated recruitment of inflammatory, TNF-α-producing
macrophages to the lungs of influenza-infected animals resulting
in pulmonary oedema, haemorrhaging of bronchial blood vessels
and apoptosis of lung epithelial cells [28–31]. Following caspase-
3 staining of lung sections prepared from the mice, we failed
to detect apoptotic cells thereby precluding a comparison of cell
death in the lungs of WT and IL-6−/− mice. The greater degree
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Figure 6. Adaptive immune responses are diminished in IL-6−/− mice. (A and B) BALF was aspirated from WT and IL-6−/− mice at day 7 post-
infection and the airway infiltrating cells isolated. (A) The numbers of CD4+ (left axis), IFN-γ-producing CD4+ cells (right axis) and (B) CD8+ (left axis)
and IFN-γ−producing CD8+ cells (right axis) were determined by flow cytometry. (C) Total numbers of CD8+ NP34-tetramer+ cells were determined
from the BALF. (D) The total number of CD8+ NP34-tetramer+ cells was determined in the mediastinal lymph node that drains the pulmonary
cavity. Results are expressed as the mean + SEM, n = 6 mice/group from one experiment representative of three performed. The significances of
differences between WT and IL-6−/− mice were assessed using Mann–Whitney test, *p < 0.05.
of inflammation observed in mice lacking IL-6 is however consis-
tent with previous studies [27], and indicates that the pathology
observed in the IL-6−/− mice is caused by virus-driven inflamma-
tory responses.
What is responsible for the failure to control virus? Previous
data by Dienz et al. [27] report a role for IL-6 in promoting the
survival of lung neutrophils, important for limiting virus repli-
cation during acute influenza infection. Significantly, infiltrating
neutrophils from IL-6−/− mice show impaired effector functions
(phagocytosis and respiratory burst activity) [32]. During the
innate phase of the influenza response, we observed no differ-
ence in the numbers of neutrophils isolated from the BALF at
any of the time points examined. However, it remains possible
that these neutrophils do contribute to virus clearance and that
this is more effective in WT compared to IL-6−/− mice. Some dif-
ferences between the two experimental systems preclude direct
comparison. Most notably, in the Dienz study, mice were infected
with higher doses of influenza and virus clearance from the pul-
monary cavity was assessed by PCR to quantitate viral copy num-
ber and not by measuring the amount of infectious virus [27].
Also, by day 9 post-infection, it was reported that the numbers of
neutrophils were negligible in both WT and IL-6−/− mice, indi-
cating that neutrophils may not be critical for the resolution of
infection.
The data presented herein indicate that IL-6 clearly promotes
induction of the virus-specific T-cell response as the influenza-
specific CD8+ T-cell, and to a lesser extent the CD4+ T-cell
response, was diminished in both BALF and lung draining lymph
nodes of IL-6−/− mice. These data are in line with prior investi-
gations, which have revealed an impact of IL-6 on the control of
CD4+ T-cell responses [19, 33, 34], the differentiation of CD8+
T cells in vitro and, in certain infections, facilitating induction of
optimal CD8+ T-cell responses [12, 13, 18, 35]. Several mecha-
nisms may limit T-cell responses in the absence of IL-6. Studies
have shown that IL-6 has a role in promoting dendritic cell (DC)
maturation and effective antigen presentation in vitro [36, 37].
However, we observed no difference in either the total numbers
or the maturation status of DCs isolated from the mediastinal
lymph nodes following influenza infection (Supporting Informa-
tion Fig. 5) and we have been unable to detect any difference in
the phenotype or function of WT or IL-6−/− bone-marrow derived
DCs infected with influenza virus in vitro (data not shown). It
has been demonstrated in vivo that the presence of IL-6 pro-
motes antigen-specific expansion of CD4+ T cells by protecting
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Figure 7. T-cell proliferation and survival characteristics are altered in the absence of IL-6. BALF was aspirated from WT and IL-6−/− mice at day
7 post-infection and the airway infiltrating cells isolated. Representative flow cytometry plots depict the expression of (A) Ki67 on CD8+ T Cells,
and (B) Bcl2 on CD8+ T cells. (C) The numbers of CD8+, (D) NP-34+ tetramer+ CD8+ T cells and (E) CD4+ T cells expressing the proliferation marker
Ki67 were determined by flow cytometry. Total numbers of (F) CD8+ T cells, (G) NP-34+ tetramer+ CD8+ T cells and (H) CD4+ T cells expressing
the anti-apoptosis gene Bcl2 were also determined by flow cytometry. The significance of differences between WT and IL-6−/− mice was assessed
using the Mann–Whitney test, *p < 0.05, **p < 0.01.
them from apoptosis [24]. In line with this, we found that fewer
CD8+ and CD4+ T cells recruited to the infected lungs of IL-6−/−
mice expressed Bcl2, thus the lung-infiltrating T cells in these ani-
mals are likely to be more apoptosis prone. Moreover, significantly
fewer antigen-specific CD8+ T cells and CD4+ T cells proliferated
in the pulmonary cavity and draining lymph nodes of influenza-
infected IL-6−/− compared with WT mice. Whether this influence
of IL-6 is due to direct effects on the influenza-specific T cells
C© 2013 Cardiff University. European Journal of Immunology
published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
www.eji-journal.eu
Eur. J. Immunol. 2013. 43: 2613–2625 Immunity to infection 2621
Figure 8. Protective immune responses were
significantly reduced in IL-6−/− mice. (A) At 7–
9 weeks post-infection, all mice were rechal-
lenged with 200 pfu of X31. Mice were weighed
prior to secondary infection to provide a base-
line 100% starting weight and for 4 days there-
after. Each data point represents the mean ±
SEM for each group, n = 3–6 mice/group. (B) At
day 4 post-secondary infection mice were sac-
rificed and the lungs harvested following per-
fusion with PBS. Lungs were homogenised and
the viral load determined. Plots represent the
mean of each group + SEM, n = 6 mice/group,
4 mice/group for PR8 naı¨ve mice. (C and D) BALF
was aspirated fromWTand IL-6−/− mice at 4 days
post-secondary infection and the airway infil-
trating cells isolated. The numbers of (C) CD8+
influenza-specific tetramer+ cells, and (D) CD4+
cells were determined by flow cytometry. Plots
represent the mean + SEM, n = 6 mice/group, 4
mice/group for PR8 naı¨ve mice. (E) To determine
the proliferative capacity of antigen-specific
CD4+ T cells, spleens were isolated fromWT and
IL-6−/− mice between 7–9 weeks post-infection.
CD4+ T cells were isolated by magnetic separa-
tion and stimulated by the addition of spleno-
cytes loaded with PR8. The antigen-specific pro-
liferation of WT and IL-6−/− CD4+ T cells was
determined by thymidine incorporation at 72 h.
Each data point represents the mean ± SEM, n
= 4 mice/group. The significances of differences
between WT and IL-6−/− mice were assessed
using one-way ANOVA with Tukey–Kramers
post-hoc multicomparison test, *p < 0.05, **p <
0.01, ***p < 0.001. (F–H) Lungs were harvested
frommice at day 4 post-secondary infection and
following perfusion were formalin fixed, embed-
ded in paraffin wax, sectioned, and stained with
haematoxylin and eosin. Representative sec-
tions from influenza infected, (G) WT and (H) IL-
6−/− mice are shown. (F) Sections were scored for
the extent and severity of haemorrhage present
within the lungs of WT and IL-6−/− infected with
PR8 and rechallenged with X31 4 days previously
and PR8 naı¨ve WT and IL-6−/− mice infected
with X31 4 days earlier. Plots represent themean
haemorrhage score + SEM, n = 4–6 mice/group.
All data shown are from one experiment rep-
resentative of two performed. Statistical signifi-
cance between WT and IL-6−/− mice was deter-
mined using Mann–Whitney test, *p < 0.05.
is unclear. IL-6 could directly promote T-cell expansion and sur-
vival or act indirectly through effects on other cells. Indeed, in
this study, we observed that the ratio of CD4+Foxp3+ T cells to
CD4+Foxp3− T cells in BALF was significantly higher in IL-6−/−
mice compared with that in WT mice at day 7 post-infection (Sup-
porting Information Fig. 4). Such an alteration could explain the
reduced T-cell response observed in the IL-6−/− mice. Although no
such difference was observed in the ratio of CD4+Foxp3+ T cells
to influenza-specific CD8+ tetramer+ T cells, an elevated Treg-
cell to CD4+Foxp3− T-cell ratio could still account, through com-
promised CD4+ T-cell help, for the decreased influenza-specific
CD8+ T-cell responses measured in the IL-6−/− animals. Treg cells
have previously been shown, however, to impact on influenza-
specific CD4+ T-cell responses in IL-6−/− mice. Using a differ-
ent strain of influenza virus (E61–13-H17 (H17)), which repli-
cates less efficiently in mice than the mouse-adapted PR8 virus
adopted here, memory but not primary influenza-specific CD4+
T-cell responses were significantly impaired in IL-6−/− animals;
an effect that was due in part to the induction of influenza-specific
Treg cells in the IL-6−/− mice, but not wild-type mice [20]. Our
current study implies that following infection with a pathogenic
dose of influenza virus, IL-6 deficiency results in enhanced
induction of Treg cells during the primary phase of infection,
which may limit both the proliferation and survival of antiviral
T cells.
We also observed an impairment of memory T-cell responses
in the IL-6−/− animals assessed in this study, which compromised
the ability of the mice to clear infection following challenge with
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a heterosubtypic influenza virus. It has been reported previously
that the size of the memory T-cell pool reflects the clonal burst size
following initial stimulation with antigen [38]. Whilst we were
unable to accurately quantitate, using tetramers, the frequencies
of antigen-specific T cells in mice just prior to rechallenge, it is
likely that the reduced recall response in the IL-6−/− mice reflects
both the compromised primary response as well as the ability of
the memory T cells to expand optimally upon second encounter
with antigen.
Curiously, we observed a significantly increased degree of lung
damage in IL-6−/− mice infected with a second influenza virus. It
has been reported previously that IL-6 is required for regenera-
tion of intestinal epithelial cells [39]. It is therefore possible that
IL-6 plays an important role in repair of damaged lung epithelia
following respiratory virus infection. These findings are of direct
relevance to understanding the potential impact of drugs designed
to interfere with IL-6 signalling, e.g. tocilizumab, an IL-6R mAb,
used to treat rheumatoid arthritis (reviewed in [40]). Indeed, due
to the impact of IL-6 on intestinal epithelial regeneration, the drug
is not recommended for individuals with diverticular disease. It is
possible that IL-6 blockade may also exacerbate lung pathology
during respiratory virus infections. Such experiments represent
an important progression of this study, where the impact of IL-6
blockade is tested not in IL-6−/− mice, but in mice given drugs to
inhibit IL-6 signalling.
Collectively, these data indicate that following infection with
pathogenic titres of influenza virus, IL-6 is critical for the
generation of robust influenza-specific T-cell responses in vivo, as
demonstrated by a significant reduction in influenza-specific CD8+
and CD4+ T cells recruited to the lungs of mice following primary
and secondary challenge with influenza virus. We hypothesise that
as a result of this compromised T-cell response, IL-6−/− mice strug-
gle to control the infection resulting in virus-driven inflammatory
innate responses and life-threatening immunopathology.
Whilst our data are consistent with these conclusions, we
cannot rule out that IL-6 also modulates the immune response
to influenza virus through its ability to direct anti-inflammatory
activities. Xing et al. [35] previously showed, using a model of
endotoxin-induced acute lung inflammation that IL-6 suppresses
expression of pro-inflammatory cytokines, including TNF-α. A sim-
ilar regulation of plasma TNF-α levels has also been reported in
IL-6−/− mice following Streptococcus pneumonia infection [14].
Studies by Barton et al. [41] using a septic shock model demon-
strated that IL-6 antagonised the effect of TNF-α in vivo, protect-
ing against TNF-α induced mortality. In vivo blockade of TNF-α in
murine influenza significantly reduces pulmonary immunopathol-
ogy and cellular infiltrate without preventing virus clearance
[42]. Thus, in our own study, we cannot rule out the possibil-
ity that the absence of IL-6 exacerbates influenza-driven inflam-
matory responses in a manner that is independent of virus
load.
Overall, the study presented herein underpins the impor-
tance of boosting the adaptive response to influenza virus whilst
suppressing the inflammatory response. IL-6 plays an essential role
in maintaining this balance.
Materials and methods
Mice
Female C57BL/6 wild type (WT) mice and IL-6−/− mice were
sourced from Charles River UK and used for experiments at 8–
10 weeks of age. Mice were housed in S containers that were
ventilated with HEPA-filtered air, and allowed access to standard
mouse chow and water ad libitum. All experimental procedures
conducted were in compliance with UK Home Office Regulations.
Murine influenza infection
Recombinant Influenza A virus strain A-PR8–34 (PR8, H1N1), and
A/X31 (X31, H3N2) were obtained from the National Institute for
Medical Research (London, UK) [43]. PR8 and X31 were amplified
in embryonated chicken eggs and in vitro Madin Darby canine
kidney cell virus titration assays conducted to determine viral titre
as described previously [44].
Prior to infection mice were weighed and ear coded. Mice were
infected intra-nasally (i.n.) with 50 plaque-forming units (pfu) of
PR8 in 50 μL of sterile PBS, under light anaesthesia for primary
acute influenza infection studies, days 0–7. For memory experi-
ments, mice were infected with 25 pfu of PR8 as above. Where
stated, mice were rechallenged at 7–9 weeks post-primary infec-
tion with 200 pfu of X31 in 50 μL of sterile PBS under light
anaesthesia. Body weight was recorded daily during the course of
infection until mice were sacrificed or until day 26 for memory
studies. Rectal temperatures were measured prior to the com-
mencement of the study and until day 7 for acute studies.
In vitro virus quantitation assay
The right-hand lung lobes were extracted following perfusion and
placed immediately into 1 mL of serum-free IMDM (Invitrogen)
on ice. Lungs were homogenised and stored at −80◦C. Lung viral
load was determined using the previously described virus titration
assay [44]. Briefly, serial twofold dilutions of lung homogenates
were incubated with Madin Darby canine kidney cells with a
methylcellulose overlay in a 24-well plate for 48 h. Cells were
fixed, permeabilised and stained with a monoclonal antibody spe-
cific for the PR8 haemagglutinin, for X31 an anti-influenza nucle-
oprotein antibody (AbD Serotec) was used. Cells were incubated
with a peroxidase-labelled secondary antibody (BioRad) and the
plate was developed using AEC reagents (Sigma). Each stained
cell was counted and the total pfu per lung was calculated.
Lung immunohistochemistry
Lungs were perfused with 5 mL of PBS and placed into 10%
neutral-buffered formalin saline. Fixed lungs were embedded into
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paraffin and 5 μm sections cut. Sections were stained with haema-
toxylin and eosin and were scored blinded. Lungs were scored
using a modified scoring criteria from Longhi et al. [45] and
Ashcroft et al. [46], namely severity of interstitial leukocyte infil-
tration (0–3), and the magnitude of perivascular lymphoid aggre-
gate (0–3) combined with the extent of perivascular lymphocytic
aggregate within each section (0–10). The degree of haemorrhage
(0–3) and extent of pulmonary fibrosis (0–3) was also scored. The
mean score for each clinical parameter was then calculated and
compared between groups.
Bronchoalveolar lavage (BAL)
Mice were sacrificed and the lungs lavaged immediately with
1 mL of PBS/EDTA. Approximately 90% of the total instilled vol-
ume was routinely recovered. BAL fluid (BALF) was kept on ice
before centrifugation at 3000 rpm for 10 min at 4◦C. Cell pel-
lets were resuspended in an FACS buffer and the cellular content
quantified by flow cytometry. BALF was aliquoted and stored at
−80◦C for cytokine analysis.
Flow cytometry
Cells isolated from the BALF were stained with fluorochrome-
conjugated antibodies or MHC-I tetramers. Anti-NK1.1-FITC
(BD), Anti-CD3-PerCP (BD), Anti-CD11c-PE-Cy7 (BD), Anti-
GR-1-V450 (BD), Anti-CD11b-allophycocyanin-Cy7 (BD),
Anti-CD4-Pacific Blue (BD), Anti-CD8-PerCP-Cy5.5 (BD), Anti-
CD8-allophycocyanin-Cy7 (BD), Anti-IFN-γ-PerCP-Cy5.5 (BD),
Anti-7/4-PE (AbD Serotec), Anti-F4/80-allophycocyanin (AbD
Serotec), Anti-IL-10-allophycocyanin (eBioscience), Anti-TNF-α-
FITC (eBioscience), Anti-Ki67-FITC (BD), Anti-Bcl2-PE (BD) and
Anti-FoxP3-PE-Cy7 (eBioscience) were used throughout these
studies. The PE-labelled tetramer (Db-ASNENMETM) used in
this study was generated in-house using previously described
methods [47]. Cells stained with directly conjugated antibodies
were incubated with 1–2 μg/mL of antibody for 30 min at 4◦C
prior to washing and resuspending in FACS buffer (PBS, 2%
FCS, 2 mM EDTA). Cells were fixed with FACS Fix buffer (PBS,
2% FCS, 2mM EDTA, 2% formalin) prior to analysis. Cells were
acquired by flow cytometry (Cyan ADP, Beckman Coulter) and
the data analysed using Summit Software (DAKO, Colorado,
USA).
Intracellular cytokine staining of T cells was performed using
single-cell suspensions derived from BALF. Cultures were stimu-
lated at 37◦C in complete RPMI (Invitrogen, supplemented with
2 mM L-glutamine, 1 mM sodium pyruvate, 50 μg/mL peni-
cillin streptomycin and 10% foetal calf serum) with phorbol 12-
myristate 13-acetate (PMA; Sigma-Aldrich) (20 nM) and iono-
mycin (1 μg/mL; Sigma-Aldrich) for 4 h; GolgiPlug (1 μL/mL;
BD Biosciences) was added for the last 3 h. After incubation, cells
were incubated according to supplier instructions with Live/Dead
Fixable Dead Stain Kit Aqua (Invitrogen, UK) to enable gating
of live cells during analysis. Cells were washed and subsequently
surface stained for CD4 and CD8 for 30 min at 4◦C, washed, fixed
and permeabilised (Foxp3 staining kit, eBioscience), blocked for
15 min with Fc Block (BD) and stained for TNF-α and IFN-γ for
30 min at 4◦C.
For intracellular cytokine staining of inflammatory monocytic
cells, single-cell suspensions derived from BALF were stimulated
by culture at 37◦C with lipopolysaccharide (LPS; Sigma-Aldrich)
(10 mg/mL) for 5 h; GolgiPlug (BD) was added for the last
4 h. After incubation, cells were washed and subsequently sur-
face stained for CD11c, CD11b, GR-1 and 7/4 for 30 min at 4◦C,
washed, fixed and permeabilised (Foxp3 staining kit, eBioscience),
blocked for 15 min with Fc Block (BD) and stained for TNF-α and
IL-10 for 30 min at 4◦C.
Quantitation of cytokines and albumin in BALF
The level of IL-6 present in the BALF was determined using a
Flow-Cytomix bead-based immunoassay (Bender Medsystems).
Quantification of TNF-α, IFN-α, IFN-γ, IL-1β (all from R&D Sys-
tems), and CCL2 (eBioscience) in the BALF was performed
using commercial ELISA. Circulating systemic levels of serum
amyloid A and the presence of serum albumin in the BALF
were determined by ELISA (Invitrogen and Bethyl Laboratories,
respectively).
CD4+ T-cell proliferation assays
Spleens were harvested from mice previously infected with PR8
at 7–9 weeks post-infection. The CD4+ T cells were isolated by
positive selection using magnetic beads (Miltenyi Biotec). Purity
of CD4+ T cells was >95% as determined by flow cytometry.
2 × 105 CD4+ T cells were restimulated by the addition of 2 × 105
irradiated antigen-presenting cells (APCs) isolated from a na¨ıve
spleen, in Iscove’s Modified Dulbecco’s Media (IMDM) (Invitro-
gen) supplemented with 10% v:v FCS. As previously described,
APCs were pulsed for 1 h with increasing doses of UV-inactivated
PR8 virus, washed and irradiated [48]. 3H-thymidine was added
after 60 h, cells were harvested after 72 h and the counts per
minute (CPM) determined.
Statistical analyses
Statistical differences between WT and IL-6−/− mice were cal-
culated using Mann–Whitney test. The statistical differences
in Fig. 7E were assessed using one-way ANOVA with Tukey–
Kramers multiple comparison post-hoc test, used to compare
the means of WT and IL-6−/− mice. p values of ≤ 0.05
were considered significant, with values of ≤ 0.01 consid-
ered highly significant. All experiments were performed at least
twice.
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